Publicaciones en las que colabora con Soraya Otero Cuesta (24)

2018

  1. Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 27, Núm. 1, pp. 113-126

  2. The complex association between the antioxidant defense system and clinical status in early psychosis

    PLoS ONE, Vol. 13, Núm. 4

2015

  1. Gender effects on brain changes in early-onset psychosis

    European Child and Adolescent Psychiatry, Vol. 24, Núm. 10, pp. 1193-1205

  2. Predictors of functional and clinical outcome in early-onset first-episode psychosis: The child and adolescent first episode of psychosis (CAFEPS) study

    Journal of Clinical Psychiatry, Vol. 76, Núm. 11, pp. e1441-e1448

2014

  1. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 126-133

  2. Cortical morphology of adolescents with bipolar disorder and with schizophrenia

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 91-99

  3. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study

    Schizophrenia Research, Vol. 152, Núm. 1, pp. 130-138

2013

  1. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia

    Schizophrenia Research, Vol. 143, Núm. 1, pp. 125-131

  2. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder

    Schizophrenia Research, Vol. 146, Núm. 1-3, pp. 103-110

  3. The human cerebral cortex flattens during adolescence

    Journal of Neuroscience, Vol. 33, Núm. 38, pp. 15004-15010

  4. Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: Discontinuation and tolerability

    Journal of Clinical Psychopharmacology, Vol. 33, Núm. 4, pp. 463-471

2012

  1. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12

  2. Longitudinal study of neurological soft signs in first-episode early-onset psychosis

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 53, Núm. 3, pp. 323-331

  3. Progressive brain changes in children and adolescents with first-episode psychosis

    Archives of General Psychiatry, Vol. 69, Núm. 1, pp. 16-26

2011

  1. Can positive family factors be protective against the development of psychosis?

    Psychiatry Research, Vol. 186, Núm. 1, pp. 28-33

  2. Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis

    Schizophrenia Bulletin, Vol. 37, Núm. 6, pp. 1270-1280

  3. Reduced antioxidant defense in early onset first-episode psychosis: A case-control study

    BMC Psychiatry, Vol. 11

  4. Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: A 2-year longitudinal study

    Schizophrenia Bulletin, Vol. 37, Núm. 1, pp. 38-51

  5. Twelve-month follow-up of family communication and psychopathology in children and adolescents with a first psychotic episode (CAFEPS study)

    Psychiatry Research, Vol. 185, Núm. 1-2, pp. 72-77

  6. Two-year diagnostic stability in early-onset first-episode psychosis

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 52, Núm. 10, pp. 1089-1098